K-Y Liu
Overview
Explore the profile of K-Y Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
711
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mo X, Xu L, Zhang X, Liu D, Wang Y, Chen H, et al.
Bone Marrow Transplant
. 2014 Nov;
50(1):127-33.
PMID: 25387095
The aim of this study was to investigate the impact of occurrence of chronic GVHD (cGVHD) and its severity on transplantation outcomes in a consecutive cohort of AML and myelodysplastic...
12.
Sun Y, Wang J, Jiang Q, Xu L, Liu D, Zhang X, et al.
Bone Marrow Transplant
. 2014 Sep;
50(1):20-5.
PMID: 25222501
Only 30% of high-risk adult ALL patients in their first complete remission (CR1) are able to receive an HLA-matched sibling stem cell transplant. The role of haploidentical hematopoietic SCT (haplo-HSCT)...
13.
Qin X, Li G, Qin Y, Wang Y, Wang F, Liu D, et al.
Bone Marrow Transplant
. 2014 Aug;
49(10):1269-77.
PMID: 25089597
This study evaluates the prognostic significance of quantitative chimerism to monitor minimal residual disease and predict relapse in acute leukemia (AL) patients following allogeneic hematopoietic SCT (HSCT). The quantitative chimerism...
14.
Zhao X, Chang Y, Xu L, Zhang X, Liu K, Li D, et al.
Br J Cancer
. 2014 Aug;
111(6):1080-8.
PMID: 25077441
Background: Conflicting results have been reported regarding the predicative roles of alloreactive natural killer (NK) cells on the outcomes of transplantation in leukaemia patients. Methods: We prospectively analysed the human...
15.
Jiang H, Xu L, Liu D, Liu K, Chen S, Jiang B, et al.
Bone Marrow Transplant
. 2014 Jul;
49(9):1146-54.
PMID: 25046218
CML treatment with tyrosine kinase inhibitors (TKIs) has improved many patients' prognosis, but during the disease's terminal phase, the blast crisis (CML-BC), has been disappointing. Allo-HSCT is another treatment, but...
16.
Liu X, Liu K, Li P, Han S, Peng X, Shen L
Diabetes Metab
. 2014 Jul;
40(5):363-72.
PMID: 24986510
Aim: Adiponectin levels in skeletal muscle and adipose tissue have been reported to be involved in insulin resistance in rats fed with a high-fat diet (HFD). Our objective was to...
17.
Mo X, Zhao X, Liu D, Chen Y, Xu L, Zhang X, et al.
Bone Marrow Transplant
. 2014 Jun;
49(8):1070-5.
PMID: 24887381
This study aimed to compare the therapeutic effects of single umbilical cord blood transplantation (UCBT) and unmanipulated haploidentical hematopoietic SCT (haplo-HSCT) in childhood hematologic malignances. We enrolled 410 consecutive children...
18.
Wang H, Chang Y, Xu L, Liu D, Wang Y, Liu K, et al.
Bone Marrow Transplant
. 2014 Apr;
49(7):927-33.
PMID: 24777191
Systematic, standardised pretransplant risk assessment is an important tool for predicting patient outcomes following allogeneic haematopoietic SCT (HSCT). To assess the European Group for Blood and Marrow Transplantation (EBMT) risk...
19.
Liu J, Torres F, Ma Y, Zhao C, Ju L, Blair D, et al.
Appl Opt
. 2014 Mar;
53(5):841-9.
PMID: 24663262
Three-mode optoacoustic parametric amplifiers (OAPAs), in which a pair of photon modes are strongly coupled to an acoustic mode, provide a general platform for investigating self-cooling, parametric instability and very...
20.
Zhang Y, Liu D, Liu K, Xu L, Chen H, Han W, et al.
Bone Marrow Transplant
. 2014 Feb;
49(4):496-501.
PMID: 24510070
HLA-haploidentical hematopoietic SCT (HSCT) provides an opportunity for almost all patients who lack HLA-matched sibling donors. The donor availability can be increased by including the collateral related donors (CRDs). We...